Pre-made recombinant lentivirus; LV-EF1α-Gluc-Puro; LV-EF1α-hGluc-Puro; LV-EF1A-Gluc-Puro; LV-EF1A-hGluc-Puro; LV-EF1α-Gluc-IRES-Puro; LV-EF1α-hGluc-IRES-Puro; LV-EF1A-Gluc-IRES-Puro; LV-EF1A-hGluc-IRES-Puro; EF1A-hGluc-Puro Lentivirus
Product Category: Pre-made 
recombinant lentivirus; LV-EF1α-Gluc-Puro;
LV-EF1α-hGluc-Puro;
LV-EF1A-Gluc-Puro;
LV-EF1A-hGluc-Puro;
LV-EF1α-Gluc-IRES-Puro;
LV-EF1α-hGluc-IRES-Puro;
LV-EF1A-Gluc-IRES-Puro;
LV-EF1A-hGluc-IRES-Puro;
EF1A-hGluc-Puro 
Lentivirus
Description: LV-EF1α-hGluc-Puro is 
a pre-made lentivirus which over-expresses 
codon-optimized/humanized 
Gaussia luciferase (hGluc) 
under the EF1α promoter 
with co-expression of puromycin selection in a IRES cassette. 
The humanized form of Gaussia luciferase 
(hGLuc) was confirmed to be nontoxic and naturally secreted after 
over-expression in mammalian cells. hGLuc generated over 1000-fold higher 
bioluminescent signal intensity from live cell and over 100-fold higher 
intensity from viable cells alone (not including secreted luciferase) or cell 
lysates, compared to humanized forms of firefly (hFLuc) and Renilla (hRLuc) 
luciferases expressed under similar conditions. Furthermore, hGLuc showed 
200-fold higher signal intensity than hRLuc and intensity comparable to that of 
hFLuc in vivo under standard imaging conditions.  Gaussia luciferase provides a 
sensitive means of imaging gene delivery and other events in living cells in 
both tissue culture and in vivo, with a unique combination of features including 
high signal intensity, secretion, and ATP independence, thus being able to 
report from the cells and their environment in real time.  Ready to use format. 
Titer: > 
1x109 TU/mL
Selection Antibiotic: Puromycin
Purity*: In 
vivo grade and OK for both in vitro tissue culture infection and in vivo 
injection
Size: 2 
x 25 µL (Std Pack)
Storage Buffer: PBS
Infection Protocol: 

Transfer Vector Map:

* Concentrated 
via PEG precipitation followed by ultra-centrifugation 
at 25000 rpm